B+
Bull case
20%
Probability
Target price
$16.00
Analysis reference price unavailable
Analysis 2026-08-14 · RankAlpha Sentiment Codex
IMTX
ImmaticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Immatics has a differentiated PRAME-focused pipeline, multiple clinical readouts scheduled for 2026, and a stated path toward SUPRAME analysis, BLA submission and a potential 2027 launch. [#PR-2026-05-12]
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +6.9.
What can break
A modest quote near $9.47 on 2026-08-14 does not establish a reliable post-earnings reaction.
Momentum
17
Value
41
Sentiment
84
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.50 · Bull $16.00 · Bear $6.50Analysis 2026-08-14; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-14 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $17.62
Why
Momentum17 · Δ7d +4.7
Value41 · Δ7d 0.0
Sentiment84 · Δ7d +6.9
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +6.9.
Contradictions & invalidation
- • A modest quote near $9.47 on 2026-08-14 does not establish a reliable post-earnings reaction.
- • Clinical efficacy, safety, enrollment and regulatory timing remain binary risks across the portfolio.
- • The T+3 earnings follow-up lacks a confirmed Q2 company release, verified surprise, guidance commentary, transcript, or analyst-revision evidence.
Catalyst clock
2026-11-12
Unconfirmed Q2 2026 earnings follow-up
Lead driver: Sentiment · See AI snapshot
Momentum
17
9% active weight
Current posture
7d trendImproving
Δ7d
+4.7
Δ21d
-0.0
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
84
62% active weight
Current posture
7d trendImproving
Δ7d
+6.9
Δ21d
-3.6
Why this grade
Composite grade B. Momentum 16.7 / Value 41.2 / Sentiment 83.7
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-14. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$10.50
Analysis reference price unavailable
Analysis 2026-08-14 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$6.50
Analysis reference price unavailable
Analysis 2026-08-14 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.24B
Beta
1.36
Shares Out
134.1M
P/E (TTM) · Derived
-5.1
P/S (TTM)
11.93
P/FCF (TTM) · Derived
-4.87
Rev YoY
+98.0%
EPS YoY
-19.0%
Gross Margin
-
Op Margin
-555.6%
Net Debt
-$532.85M
Current Ratio
7.54
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data